1,7-phenanthroline has been researched along with verapamil in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zhu, P | 1 |
Bartlett, MC; Clarke, DM; Loo, TW | 1 |
2 other study(ies) available for 1,7-phenanthroline and verapamil
Article | Year |
---|---|
[Experimental study on myocardial protection with verapamil and salvia miltiorrhiza Bunge cardioplegia].
Topics: Animals; Calcium Channels; Cardioplegic Solutions; Cardiopulmonary Bypass; Dogs; Drug Combinations; Drugs, Chinese Herbal; Hypothermia, Induced; Myocardial Reperfusion Injury; Phenanthrolines; Plant Extracts; Potassium; Salvia miltiorrhiza; Verapamil | 1990 |
Processing mutations disrupt interactions between the nucleotide binding and transmembrane domains of P-glycoprotein and the cystic fibrosis transmembrane conductance regulator (CFTR).
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Cell Membrane; Copper; Cross-Linking Reagents; Cystic Fibrosis Transmembrane Conductance Regulator; Disulfides; Humans; Models, Biological; Mutation; Nucleotides; Phenanthrolines; Protein Binding; Protein Structure, Tertiary; Verapamil | 2008 |